Loading...
Market
Number of Clients Served by Combined Transcarent-Accolade by End of 2025?
3
Resolution / Starting Odds
Fewer than 1,400 • 25%
1,400 to 1,500 • 25%
1,501 to 1,600 • 25%
More than 1,600 • 25%
Official press releases or financial reports from Transcarent or Accolade.
Story
Transcarent to Acquire Accolade for $621 Million at $7.03 Per Share, Serving 1,400 Clients
Jan 8, 2025, 02:32 PM
Transcarent, a healthcare navigation company, has announced plans to acquire Accolade, a health benefits platform, for $621 million. The deal, which values Accolade at $7.03 per share, represents a 110% premium over its closing stock price on the previous trading day. The transaction will be financed through an equity financing led by General Catalyst and 62 Ventures, with the deal expected to close in the second quarter of 2025. Upon completion, Accolade will become a privately held company and its common stock will no longer be listed on Nasdaq. The combined company aims to serve over 1,400 employer and payer clients, enhancing Transcarent's mission to provide high-quality, affordable health and care by integrating its generative AI-powered WayFinding and care experiences with Accolade's advocacy, expert medical opinions, and primary care services.
View original story
Similar markets
Triple its client base • 25%
Increase by 50% • 25%
No significant increase • 25%
Double its client base • 25%
Reduction in orders from multiple major clients • 25%
Termination of relationship with a major client • 25%
Reduction in orders from one major client • 25%
No impact • 25%
Other • 25%
FreshBooks • 25%
Xero • 25%
QuickBooks • 25%
Less than $1 billion • 25%
$1.5 billion to $2 billion • 25%
$1 billion to $1.5 billion • 25%
More than $2 billion • 25%
15% - 25% • 25%
25% - 35% • 25%
Above 35% • 25%
Below 15% • 25%
Above 700 • 25%
Below 500 • 25%
600 to 700 • 25%
500 to 600 • 25%
Acquisition over $5 billion • 25%
Acquisition under $1 billion • 25%
Acquisition between $1 billion and $5 billion • 25%
No acquisitions • 25%
More than 10 million • 25%
5 to 10 million • 25%
1 to 5 million • 25%
Less than 1 million • 25%
Phase 1 completion • 25%
No significant milestone • 25%
Phase 3 completion • 25%
Phase 2 completion • 25%
No • 50%
Yes • 50%
$7 billion • 25%
Over $8 billion • 25%
$6 billion • 25%
$8 billion • 25%